atropine has been researched along with butaprost in 1 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (butaprost) | Trials (butaprost) | Recent Studies (post-2010) (butaprost) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 161 | 0 | 46 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kharlamb, AB; Krauss, AH; Nieves, AL; Nilsson, SF; Toris, CB; Woodward, DF | 1 |
1 other study(ies) available for atropine and butaprost
Article | Year |
---|---|
Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow.
Topics: Alprostadil; Animals; Anterior Chamber; Antihypertensive Agents; Aqueous Humor; Atropine; Ciliary Body; Dextrans; Dinoprostone; Disease Models, Animal; Female; Fluorescein-5-isothiocyanate; Fluorophotometry; Humans; Intraocular Pressure; Isometric Contraction; Macaca fascicularis; Muscle, Smooth; Ocular Hypotension; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Sclera; Tonometry, Ocular; Transfection; Uvea | 2009 |